Business Description
Embla Medical hf
ISIN : IS0000000040
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.77 | |||||
Debt-to-EBITDA | 3.86 | |||||
Interest Coverage | 4.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.83 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.9 | |||||
3-Year EBITDA Growth Rate | 23 | |||||
3-Year EPS without NRI Growth Rate | 119.9 | |||||
3-Year FCF Growth Rate | -5 | |||||
3-Year Book Growth Rate | 11.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.99 | |||||
9-Day RSI | 36.31 | |||||
14-Day RSI | 38.42 | |||||
6-1 Month Momentum % | 28.05 | |||||
12-1 Month Momentum % | 7.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.68 | |||||
Quick Ratio | 1.07 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 164.05 | |||||
Days Sales Outstanding | 56.2 | |||||
Days Payable | 35.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -0.66 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.42 | |||||
Operating Margin % | 10.94 | |||||
Net Margin % | 7.08 | |||||
FCF Margin % | 5.82 | |||||
ROE % | 8.31 | |||||
ROA % | 4.09 | |||||
ROIC % | 5.34 | |||||
ROC (Joel Greenblatt) % | 27.93 | |||||
ROCE % | 7.87 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.4 | |||||
PE Ratio without NRI | 31.4 | |||||
Shiller PE Ratio | 28.09 | |||||
Price-to-Owner-Earnings | 25.02 | |||||
PEG Ratio | 10.83 | |||||
PS Ratio | 2.25 | |||||
PB Ratio | 2.48 | |||||
Price-to-Free-Cash-Flow | 38.62 | |||||
Price-to-Operating-Cash-Flow | 19.45 | |||||
EV-to-EBIT | 24.63 | |||||
EV-to-EBITDA | 15.91 | |||||
EV-to-Revenue | 2.86 | |||||
EV-to-FCF | 49.05 | |||||
Price-to-Projected-FCF | 1.65 | |||||
Price-to-DCF (Earnings Based) | 1.95 | |||||
Price-to-DCF (FCF Based) | 2.39 | |||||
Price-to-Median-PS-Value | 0.66 | |||||
Earnings Yield (Greenblatt) % | 4.06 | |||||
FCF Yield % | 2.59 | |||||
Forward Rate of Return (Yacktman) % | 4.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Embla Medical hf Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 5,539.344 | ||
EPS (TTM) (kr) | 0.93 | ||
Beta | 0.12 | ||
Volatility % | 21.68 | ||
14-Day RSI | 38.42 | ||
14-Day ATR (kr) | 1.253879 | ||
20-Day SMA (kr) | 30.53 | ||
12-1 Month Momentum % | 7.36 | ||
52-Week Range (kr) | 25.25 - 35.7 | ||
Shares Outstanding (Mil) | 426.93 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Embla Medical hf Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Embla Medical hf Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Embla Medical hf Frequently Asked Questions
What is Embla Medical hf(OCSE:EMBLA)'s stock price today?
When is next earnings date of Embla Medical hf(OCSE:EMBLA)?
Does Embla Medical hf(OCSE:EMBLA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |